Annual FCF
-$21.25 M
+$19.37 M+47.69%
31 December 2023
Summary:
Cyclerion Therapeutics annual free cash flow is currently -$21.25 million, with the most recent change of +$19.37 million (+47.69%) on 31 December 2023. During the last 3 years, it has risen by +$52.77 million (+71.30%). CYCN annual FCF is now at all-time high.CYCN Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$1.72 M
-$610.00 K-55.15%
30 September 2024
Summary:
Cyclerion Therapeutics quarterly free cash flow is currently -$1.72 million, with the most recent change of -$610.00 thousand (-55.15%) on 30 September 2024. Over the past year, it has increased by +$5.22 million (+75.26%). CYCN quarterly FCF is now -55.15% below its all-time high of -$1.11 million, reached on 30 June 2024.CYCN Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$6.23 M
+$5.22 M+45.57%
30 September 2024
Summary:
Cyclerion Therapeutics TTM free cash flow is currently -$6.23 million, with the most recent change of +$5.22 million (+45.57%) on 30 September 2024. Over the past year, it has increased by +$20.51 million (+76.69%). CYCN TTM FCF is now at all-time high.CYCN TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CYCN Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +47.7% | +75.3% | +76.7% |
| 3 y3 years | +71.3% | +78.4% | +85.2% |
| 5 y5 years | +79.0% | +93.0% | +94.4% |
CYCN Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +71.3% | -55.1% | +86.6% | at high | +85.2% |
| 5 y | 5 years | at high | +80.5% | -55.1% | +94.4% | at high | +94.4% |
| alltime | all time | at high | +80.5% | -55.1% | +95.2% | at high | +94.5% |
Cyclerion Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$1.72 M(+55.2%) | -$6.23 M(-45.6%) |
| June 2024 | - | -$1.11 M(-40.9%) | -$11.45 M(-32.2%) |
| Mar 2024 | - | -$1.87 M(+21.4%) | -$16.90 M(-20.4%) |
| Dec 2023 | -$21.25 M(-47.7%) | -$1.54 M(-77.8%) | -$21.25 M(-20.6%) |
| Sept 2023 | - | -$6.93 M(+5.8%) | -$26.75 M(-10.0%) |
| June 2023 | - | -$6.55 M(+5.5%) | -$29.73 M(-12.5%) |
| Mar 2023 | - | -$6.21 M(-11.8%) | -$33.99 M(-16.3%) |
| Dec 2022 | -$40.61 M(+11.2%) | -$7.04 M(-29.0%) | -$40.61 M(-3.8%) |
| Sept 2022 | - | -$9.91 M(-8.3%) | -$42.20 M(+4.9%) |
| June 2022 | - | -$10.82 M(-15.7%) | -$40.21 M(+15.2%) |
| Mar 2022 | - | -$12.84 M(+48.7%) | -$34.90 M(-4.4%) |
| Dec 2021 | -$36.52 M | -$8.63 M(+8.8%) | -$36.52 M(-13.0%) |
| Sept 2021 | - | -$7.93 M(+43.9%) | -$41.97 M(-14.5%) |
| June 2021 | - | -$5.51 M(-61.9%) | -$49.10 M(-15.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$14.46 M(+2.7%) | -$57.88 M(-21.8%) |
| Dec 2020 | -$74.01 M(-32.2%) | -$14.08 M(-6.5%) | -$74.01 M(-10.0%) |
| Sept 2020 | - | -$15.06 M(+5.3%) | -$82.28 M(-10.3%) |
| June 2020 | - | -$14.30 M(-53.3%) | -$91.68 M(-11.5%) |
| Mar 2020 | - | -$30.59 M(+36.9%) | -$103.60 M(-5.0%) |
| Dec 2019 | -$109.10 M(+8.1%) | -$22.34 M(-8.7%) | -$109.10 M(-2.4%) |
| Sept 2019 | - | -$24.46 M(-6.7%) | -$111.73 M(-1.8%) |
| June 2019 | - | -$26.22 M(-27.3%) | -$113.73 M(+3.0%) |
| Mar 2019 | - | -$36.09 M(+44.5%) | -$110.44 M(+9.4%) |
| Dec 2018 | -$100.94 M(+22.2%) | -$24.97 M(-5.7%) | -$100.94 M(+32.9%) |
| Sept 2018 | - | -$26.46 M(+15.5%) | -$75.97 M(+53.5%) |
| June 2018 | - | -$22.92 M(-13.8%) | -$49.51 M(+86.2%) |
| Mar 2018 | - | -$26.59 M | -$26.59 M |
| Dec 2017 | -$82.62 M | - | - |
FAQ
- What is Cyclerion Therapeutics annual free cash flow?
- What is the all time high annual FCF for Cyclerion Therapeutics?
- What is Cyclerion Therapeutics annual FCF year-on-year change?
- What is Cyclerion Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Cyclerion Therapeutics?
- What is Cyclerion Therapeutics quarterly FCF year-on-year change?
- What is Cyclerion Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Cyclerion Therapeutics?
- What is Cyclerion Therapeutics TTM FCF year-on-year change?
What is Cyclerion Therapeutics annual free cash flow?
The current annual FCF of CYCN is -$21.25 M
What is the all time high annual FCF for Cyclerion Therapeutics?
Cyclerion Therapeutics all-time high annual free cash flow is -$21.25 M
What is Cyclerion Therapeutics annual FCF year-on-year change?
Over the past year, CYCN annual free cash flow has changed by +$19.37 M (+47.69%)
What is Cyclerion Therapeutics quarterly free cash flow?
The current quarterly FCF of CYCN is -$1.72 M
What is the all time high quarterly FCF for Cyclerion Therapeutics?
Cyclerion Therapeutics all-time high quarterly free cash flow is -$1.11 M
What is Cyclerion Therapeutics quarterly FCF year-on-year change?
Over the past year, CYCN quarterly free cash flow has changed by +$5.22 M (+75.26%)
What is Cyclerion Therapeutics TTM free cash flow?
The current TTM FCF of CYCN is -$6.23 M
What is the all time high TTM FCF for Cyclerion Therapeutics?
Cyclerion Therapeutics all-time high TTM free cash flow is -$6.23 M
What is Cyclerion Therapeutics TTM FCF year-on-year change?
Over the past year, CYCN TTM free cash flow has changed by +$20.51 M (+76.69%)